Magic Investigators - Steering committee

Steering committee

Inês Barroso

University of Exeter, Exeter, UK

Inês leads the study Group at the University of Exeter, which uses genetic and genomic approaches to understand the aetiology of common and rare forms of metabolic disease.

Email: ines.barroso@exeter.ac.uk

Michael Boehnke

Department of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan

Mike's research focuses on the development of statistical methods for human gene mapping and their application to understand the genetic basis for type 2 diabetes and related traits and bipolar disorder

Email: boehnke@umich.edu

Claudia Langenberg

Precision Healthcare University Research Institute, Queen Mary University of London

Claudia Langenberg is Director of the Precision Healthcare University Research Institute and Professor of Medicine and Population Health at Queen Mary University of London, UK, Honorary Consultant Physician in Public Health at the Department of Health and Social Care and Barts NHS Trust, and Professor of Computational Medicine at the Berlin Institute of Health at Charité, Germany. Her research is focused on the genetic basis of metabolic control, and her team studies its effects on health through integration of molecular with clinical data in large-scale patient and population-based studies.

Email: claudia.langenberg@qmul.ac.uk

James Meigs

Professor of Medicine, Harvard Medical School; General Medicine Division, Massachusetts General Hospital

Dr Meigs is Professor of Medicine at Harvard Medical School and Massachusetts General Hospital. Dr. Meigs has been a practicing primary care general internist at MGH for over 30 years. During this time his research interest has been the cause and prevention of type 2 diabetes and cardiovascular disease. In 2009, he was awarded the American Diabetes Association’s Kelly West Award for Outstanding Achievement in Diabetes Epidemiology. He is the principal investigator on many NIH grants and is has mentored over 50 early career scientists, supported in part by an NIDDK K24 award. For over 20 years he has been the Director of the MGH Division of Clinical Research Comparative Effectiveness Unit, where he mentors and facilitates clinical research design for investigators across MGH.

Email: jmeigs@mgh.harvard.edu

Inga Prokopenko

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford; Wellcome Centre for Human Genetics, University of Oxford

Inga's work is focused on the genetics of Type 2 Diabetes (T2D) and related quantitative glycaemic and other metabolic traits

Email: inga@well.ox.ac.uk

Robert Sladek

Departments of Medicine and Human Genetics, McGill University, Montreal

Robert's group are involved in Functional characterization of risk loci for type 2 diabetes; developing strategies to identify causative genetic polymorphisms that underlie disease risk loci and determine their effects on cell physiology and gene regulation; and identify genetic variants that predispose to type 2 diabetes

Email: robert.sladek@mcgill.ca

Rona Strawbridge

School of Health and Wellbeing, University of Glasgow, UK; Department of Medicine Solna, Karolinska Institutet, Sweden

Rona's research uses genetics to explore the connection between mental health and cardiovascular disease, with a focus on glucometabolic components

Email: rona.strawbridge@glasgow.ac.uk

Richard Watanabe

Departments of Preventive Medicine and Physiology & Biophysics, Keck School of Medicine of USC Los Angeles, California

Richard's primary interests lie in the pathophysiology and genetics of type 2 diabetes mellitus and obesity

Email: rwatanab@usc.edu

Past steering committee members

Gonçalo Abecasis - goncalo@umich.edu: Center for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan
Nabila Bouatia-Naji - nabila.bouatia-naji@inserm.fr: INSERM UMRS 970, Paris Cardiovascular Research Center at the Hopital Européen George Pampidou, Sorbonne Paris Cité, France 192
George Dedoussis - dedousi@hua.gr: Department of Dietetics-Nutrition, Harokopio, University of Athens
Jose Florez - jcflorez@partners.org: Center for Human Genetic Research and Diabetes Unit, Massachusetts General Hospital, Cambridge, Massachusetts; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts; Department of Medicine, Harvard Medical School, Cambridge, Massachusetts
Anders Hamsten - Anders.Hamsten@ki.se: Atherosclerosis Research Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Erik Ingelsson - Erik.Ingelsson@ki.se: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Mark McCarthy - mark.mccarthy@drl.ox.ac.uk: Wellcome Centre for Human Genetics, University of Oxford; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford
Nicole Soranzo - ns6@sanger.ac.uk: Wellcome Sanger Institute, Cambridge, United Kingdom
Nick Wareham - nick.wareham@mrc-epid.cam.ac.uk: MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK
Leif Groop - Leif.Groop@med.lu.se: Lund University Diabetes Centre, Department of Clinical Sciences Malmoe, Diabetes and Endocrinology, Lund University